BridgeMD
New treatment option for Rare Diseases
Official title Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN
ClinicalTrials.gov ID: NCT05499091
What this study is testing
- What it's testing
- Next generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet described in human pathology.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patient :
- Child or adult affected by a rare disease whose molecular functions are not known, or whose pathophysiologic mechanism are not fully understood.
- Patient included inside the BaMaRa (French rare disease national data bank) database dedicated to the rare diseases.
- Patient Affiliated to the French social security system.
- Patient consent form or legal representative consent form obtained. Patient's parent :
You likely can't join if
- Poor understanding of the French language
- Legal of administrative liberty deprivation
- Psychiatric force care
See the full eligibility criteria
- Patient :
- Child or adult affected by a rare disease whose molecular functions are not known, or whose pathophysiologic mechanism are not fully understood.
- Patient included inside the BaMaRa (French rare disease national data bank) database dedicated to the rare diseases.
- Patient Affiliated to the French social security system.
- Patient consent form or legal representative consent form obtained. Patient's parent :
- Parent of a patient affected by a rare disease whose molecular functions are not known, or whose pathophysiologic mechanism are not fully understood.
- Parent included in the BaMaRa database.
- Parent affiliated to the French social security system.
- Parent consent form obtained for himself/herself. Patient's brother or sister :
- Brother or sister of a patient (underage or adult) affected by a rare disease whose molecular functions are not known, or whose pathophysiologic mechanism are not fully understood.
- Brother or sister included in the BaMaRa database.
- Brother or sister affiliated to the French social security system.
- Brother or sister consent form obtained for themselves or from their legal representative.
- Poor understanding of the French language
- Legal of administrative liberty deprivation
- Psychiatric force care
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.